Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis

ABSTRACT: Necrotic enteritis (NE) is a widespread infectious disease caused by Clostridium perfringens that inflicts major economic losses on the global poultry industry. Due to regulations on antibiotic use in poultry production, there is an urgent need for alternative strategies to mitigate the ne...

Full description

Bibliographic Details
Main Authors: D. Goo, U.D. Gadde, W.K. Kim, C.G. Gay, E.W. Porta, S.W. Jones, S. Walker, H.S. Lillehoj
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Poultry Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0032579123003607
_version_ 1797676339153600512
author D. Goo
U.D. Gadde
W.K. Kim
C.G. Gay
E.W. Porta
S.W. Jones
S. Walker
H.S. Lillehoj
author_facet D. Goo
U.D. Gadde
W.K. Kim
C.G. Gay
E.W. Porta
S.W. Jones
S. Walker
H.S. Lillehoj
author_sort D. Goo
collection DOAJ
description ABSTRACT: Necrotic enteritis (NE) is a widespread infectious disease caused by Clostridium perfringens that inflicts major economic losses on the global poultry industry. Due to regulations on antibiotic use in poultry production, there is an urgent need for alternative strategies to mitigate the negative effects of NE. This paper presents a passive immunization technology that utilizes hyperimmune egg yolk immunoglobulin Y (IgY) specific to the major immunodominant antigens of C. perfringens. Egg yolk IgYs were generated by immunizing hens with 4 different recombinant C. perfringens antigens, and their protective effects against NE were evaluated in commercial broilers. Six different spray-dried egg powders were produced using recombinant C. perfringens antigens: α-toxin, NE B-like toxin (NetB; EB), elongation factor-Tu (ET), pyruvate:ferredoxin oxidoreductase, a mixture of 4 antigens (EM-1), and a nonimmunized control (EC). The challenged groups were either provided with different egg powders at a 1% level or no egg powders (EN). The NE challenge model based on Eimeria maxima and C. perfringens dual infection was used. In Experiments 1 and 2, the EB and ET groups exhibited increased body weight gain (BWG; P < 0.01), decreased NE lesion scores (P < 0.001), and reduced serum NetB levels (P < 0.01) compared to the EN and EC groups. IgY against NetB significantly reduced Leghorn male hepatocellular cytotoxicity in an in vitro test (P < 0.01). In Experiment 3, the protective effect of the IgYs mixture (EM-2) against C. perfringens antigens (NetB and EFTu) and Eimeria antigens (elongation factor-1-alpha: EF1α and Eimeria profilin: 3-1E) was tested. The EM-2 group showed similar body weight, BWG, and feed intake from d 7 to 22 compared to the NC group (P < 0.05). On d 20, the EM-2 group showed comparable intestinal permeability, NE lesion scores, and jejunal NetB and collagen adhesion protein levels to the NC group (P < 0.05). In conclusion, dietary mixture containing antibodies to NetB and EFTu provides protection against experimental NE in chickens through passive immunization.
first_indexed 2024-03-11T22:27:34Z
format Article
id doaj.art-32254d4f484943a382fa8f8fcc46ec54
institution Directory Open Access Journal
issn 0032-5791
language English
last_indexed 2024-03-11T22:27:34Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series Poultry Science
spelling doaj.art-32254d4f484943a382fa8f8fcc46ec542023-09-24T05:13:43ZengElsevierPoultry Science0032-57912023-10-0110210102841Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritisD. Goo0U.D. Gadde1W.K. Kim2C.G. Gay3E.W. Porta4S.W. Jones5S. Walker6H.S. Lillehoj7Department of Poultry Science, University of Georgia, Athens, GA, USAAnimal Bioscience and Biotechnology Laboratory, Beltsville Agricultural Research Center, Agricultural Research Service, USDA, Beltsville, MD, USADepartment of Poultry Science, University of Georgia, Athens, GA, USAOffice of National Program-Animal Health, Agricultural Research Service, USDA, Beltsville, MD, USAArkion Life Sciences, New Castle, DE, USAArkion Life Sciences, New Castle, DE, USAArkion Life Sciences, New Castle, DE, USAAnimal Bioscience and Biotechnology Laboratory, Beltsville Agricultural Research Center, Agricultural Research Service, USDA, Beltsville, MD, USA; Corresponding author:ABSTRACT: Necrotic enteritis (NE) is a widespread infectious disease caused by Clostridium perfringens that inflicts major economic losses on the global poultry industry. Due to regulations on antibiotic use in poultry production, there is an urgent need for alternative strategies to mitigate the negative effects of NE. This paper presents a passive immunization technology that utilizes hyperimmune egg yolk immunoglobulin Y (IgY) specific to the major immunodominant antigens of C. perfringens. Egg yolk IgYs were generated by immunizing hens with 4 different recombinant C. perfringens antigens, and their protective effects against NE were evaluated in commercial broilers. Six different spray-dried egg powders were produced using recombinant C. perfringens antigens: α-toxin, NE B-like toxin (NetB; EB), elongation factor-Tu (ET), pyruvate:ferredoxin oxidoreductase, a mixture of 4 antigens (EM-1), and a nonimmunized control (EC). The challenged groups were either provided with different egg powders at a 1% level or no egg powders (EN). The NE challenge model based on Eimeria maxima and C. perfringens dual infection was used. In Experiments 1 and 2, the EB and ET groups exhibited increased body weight gain (BWG; P < 0.01), decreased NE lesion scores (P < 0.001), and reduced serum NetB levels (P < 0.01) compared to the EN and EC groups. IgY against NetB significantly reduced Leghorn male hepatocellular cytotoxicity in an in vitro test (P < 0.01). In Experiment 3, the protective effect of the IgYs mixture (EM-2) against C. perfringens antigens (NetB and EFTu) and Eimeria antigens (elongation factor-1-alpha: EF1α and Eimeria profilin: 3-1E) was tested. The EM-2 group showed similar body weight, BWG, and feed intake from d 7 to 22 compared to the NC group (P < 0.05). On d 20, the EM-2 group showed comparable intestinal permeability, NE lesion scores, and jejunal NetB and collagen adhesion protein levels to the NC group (P < 0.05). In conclusion, dietary mixture containing antibodies to NetB and EFTu provides protection against experimental NE in chickens through passive immunization.http://www.sciencedirect.com/science/article/pii/S0032579123003607broilerClostridium perfringensegg yolk immunoglobulin Ynecrotic enteritisnecrotic enteritis B-like toxin
spellingShingle D. Goo
U.D. Gadde
W.K. Kim
C.G. Gay
E.W. Porta
S.W. Jones
S. Walker
H.S. Lillehoj
Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis
Poultry Science
broiler
Clostridium perfringens
egg yolk immunoglobulin Y
necrotic enteritis
necrotic enteritis B-like toxin
title Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis
title_full Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis
title_fullStr Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis
title_full_unstemmed Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis
title_short Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis
title_sort hyperimmune egg yolk antibodies developed against clostridium perfringens antigens protect against necrotic enteritis
topic broiler
Clostridium perfringens
egg yolk immunoglobulin Y
necrotic enteritis
necrotic enteritis B-like toxin
url http://www.sciencedirect.com/science/article/pii/S0032579123003607
work_keys_str_mv AT dgoo hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis
AT udgadde hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis
AT wkkim hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis
AT cggay hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis
AT ewporta hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis
AT swjones hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis
AT swalker hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis
AT hslillehoj hyperimmuneeggyolkantibodiesdevelopedagainstclostridiumperfringensantigensprotectagainstnecroticenteritis